234 related articles for article (PubMed ID: 12699409)
1. Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency.
Köller MD; Kiener HP; Aringer M; Graninger WB; Meuer S; Samstag Y; Smolen JS
Clin Exp Immunol; 2003 May; 132(2):225-31. PubMed ID: 12699409
[TBL] [Abstract][Full Text] [Related]
2. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
3. In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.
Ben-Amor A; Leite-De-Moraes MC; Lepault F; Schneider E; Machavoine F; Arnould A; Chatenoud L; DY M
Clin Exp Immunol; 1996 Mar; 103(3):491-8. PubMed ID: 8608651
[TBL] [Abstract][Full Text] [Related]
4. Rat NKR-P1+ CD3+ T cells: selective proliferation in interleukin-2, diverse T-cell-receptor-Vbeta repertoire and polarized interferon-gamma expression.
Badovinac V; Boggiano C; Trajković V; Frey AB; Vujanović NL; Gold DP; Mostarica-Stojković M; Vukmanović S
Immunology; 1998 Sep; 95(1):117-25. PubMed ID: 9767466
[TBL] [Abstract][Full Text] [Related]
5. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
Borg AJ; Kumagai-Braesch M; Möller E
Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of cytokine and NFAT gene expression in human interleukin-2-dependent T lymphoblasts stimulated via T-cell receptor.
Sareneva T; Matikainen S; Vanhatalo J; Melén K; Pelkonen J; Julkunen I
Immunology; 1998 Mar; 93(3):350-7. PubMed ID: 9640245
[TBL] [Abstract][Full Text] [Related]
8. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction.
Walz G; Stevens C; Zanker B; Melton LB; Clark SC; Suthanthiran M; Strom TB
Cell Immunol; 1991 May; 134(2):511-9. PubMed ID: 1827050
[TBL] [Abstract][Full Text] [Related]
10. Impaired T cell proliferation in acute dengue infection.
Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
[TBL] [Abstract][Full Text] [Related]
11. Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates.
Pirenne-Ansart H; Paillard F; De Groote D; Eljaafari A; Le Gac S; Blot P; Franchimont P; Vaquero C; Sterkers G
Pediatr Res; 1995 Jan; 37(1):64-9. PubMed ID: 7700735
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
[TBL] [Abstract][Full Text] [Related]
13. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1.
Cerwenka A; Kovar H; Majdic O; Holter W
J Immunol; 1996 Jan; 156(2):459-64. PubMed ID: 8543794
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes.
Borger P; Kauffman HF; Postma DS; Esselink MT; Vellenga E
Immunology; 1999 Feb; 96(2):207-14. PubMed ID: 10233697
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
[TBL] [Abstract][Full Text] [Related]
16. Activation-induced T cell apoptosis by monocytes from stem cell products.
Ino K; Ageitos AG; Singh RK; Talmadge JE
Int Immunopharmacol; 2001 Jul; 1(7):1307-19. PubMed ID: 11460311
[TBL] [Abstract][Full Text] [Related]
17. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
[TBL] [Abstract][Full Text] [Related]
19. Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli.
Ebert EC
Gastroenterology; 1989 Dec; 97(6):1372-81. PubMed ID: 2684720
[TBL] [Abstract][Full Text] [Related]
20. Dual-color flow cytometric analysis of phenotype, activation marker expression, and proliferation of mitogen-stimulated bovine lymphocyte subsets.
Quade MJ; Roth JA
Vet Immunol Immunopathol; 1999 Jan; 67(1):33-45. PubMed ID: 9950352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]